Menu Close

About Us

WE ARE CORONA REMEDIES PVT LTD

Our name is inspired from the blazing glow around the sun that shines through during a total solar eclipse spreading hope, growth and prosperity.

We are CORONA Remedies. Our journey started in 2004, with a commitment to create better quality of health for all by being at the forefront of research, manufacturing and marketing of high quality products.

Our reach all over India, faster acceptance among the medical fraternity and our path breaking efforts proudly positioned us as one of the India’s youngest company to be into top 40 pharmaceutical companies.

This prodigious success is a result of our continuous commitment to innovative product development and manufacturing capabilities at world class PIC compliant capability that adhere to global quality standards.

We are among the leaders in Women Healthcare, and have a strong presence in various therapies such as Anti-hypertensive, Diabetes, Neuropathy, Hormones, Pain management, Dermatology, Bone Health, Anti-ulcerant & Nutritional supplements.

Our Vision

To achieve good health for every individual, society and the nation as a whole by becoming one of the top pharmaceutical companies in the world.

Our Mission

To be an ethical, transparent, spirited, and vibrant organization with a progressive outlook, is to make available a range of innovative, value-added and evidence-based products.

Board of Directors

John Doe

Director

Add team member description here. Remove the text if not necessary.

John Doe

Director

Add team member description here. Remove the text if not necessary.

John Doe

Director

Add team member description here. Remove the text if not necessary.

John Doe

Director

Add team member description here. Remove the text if not necessary.

Growth Story

2004
Founded Year with its 1st Division: PIONEER
2005
Launched 2ND Division: XEMX
2006
Set up our first manufacturing plant at Solan, Himachal Pradesh
2007
Started Geographical expansion in East & South India
2008
We launched another speciality division for Women’s healthcare and further expanded in Central India
2008
Entry into the international market. First export operations initiated with Kenya
2009
We entered into North India marking our PAN India presence
2009
Expansion of Solan plant with liquids and hormones manufacturing
2010
We have entered in Top 100 pharmaceutical companies
2012
We ventured into other countries like Mauritius, Nigeria, Zambia and Srilanka
2013
We secured 50th rank in IPM
2015
We ventured in to the South East Asian Countries such as Philippines, Myanmar, Cambodia, Vietnam and Thailand
2016
We ventured into West Africa countries as a contract manufacturer to Strides Arco lab
2017
We acquire brands like Vitneurin, Stelbid, Dilo DX & Dilo BM from GSK and consolidated our position in nutraceuticals, respiratory and gastroenterology segments
2018
We acquire brands like Obimet range and Thyrocab range from Abbott India Ltd. & strengthened ourselves in therapies like Diabetes & Thyroid management
2019
We have initiated the process of registering our own brands in West Africa and other CIS countries
2020
Strategic alliance with La-Chandra Pharmalab strengthening gynecological & Hormonal product range
2021
Commencement of EU GMP Compliant Plant.
2021
Strategic co-marketing partnership with Albert David for Human Placental Extract
2022
Divisionalization of marketing division & addition of two new divisions – Solaris & Radiance to strengthen our Gynaecology & CVD segment

Milestones & Recognitions